• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Carasent

22.20 SEK

-1.77 %

1,642 following

CARA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.77 %
-7.11 %
-3.69 %
-19.13 %
-17.93 %
-21.55 %
+38.14 %
-31.43 %
+0.37 %

Carasent is an IT company. The company delivers products and services within communication and IT infrastructure specifically aimed at the healthcare industry. Examples of solutions include proprietary cloud-based services, email management, mobile solutions, and security and backup solutions. Customers are mainly found within health and care, finance and telecom. The company was originally established in 1997 and is headquartered in Gothenburg.

Read more
Market cap
1.56B SEK
Turnover
1.44M SEK
Revenue
343.82M
EBIT %
2.74 %
P/E
44.4
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
Carnegielta commissioned research pre-Q4 Inderes Carnegie Access: Carasent: We expect a solid end to the year – Q4 preview -... Carnegie has published a new commissioned research report on Carasent.To access the full report and subscribe to future updates, visit https://www.carnegie...
1/29/2025, 6:41 AM
by timontti
6
redeye.se Carasent (Q3 Review): In good shape for exciting 2026 Redeye retains its positive view of Carasent following the Q3 report. Organic ARR growth remains solid, and margins are improving substantially. The company has several ongoing growth initiatives tha Carasent’s profitability...
10/16/2025, 3:46 PM
by Diviner
2
I have thousands of euros worth of Carasent ASA. It is no longer traded, so I am stuck with the shares. I thought there would have been an automatic exchange to Carasent AB… Is anyone else in the same situation? What should I do? How can I prevent this in the future?
6/23/2025, 7:38 AM
by Loue
1
redeye.se Carasent: Back in Shape in 2024 – More to Come Redeye retains its positive view of Carasent following the Q4 report. Despite a somewhat softer Q4 report than expected and a softened outlook for H1 2025, we changed our Base Case driven by revised New Base Case SEK28 (NOK26...
2/17/2025, 6:47 AM
by timontti
1
Redeye expectations for the Q1 report on Feb 13th
2/6/2025, 3:08 PM
by timontti
1
Inderes First day of trading in Carasent AB (publ) on Nasdaq Stockholm - Inderes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND...
12/9/2024, 9:27 AM
by timontti
1
Which intermediary? Contact them, and the matter should be resolved.
6/23/2025, 1:51 PM
by Turskanpyytäjä
0
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10/7
2026

Interim report Q2'26

15/10
2026

Interim report Q3'26

4/2
2027

Annual report '26

Regulatory press release5/29/2026, 5:00 AM

Change in the number of shares and votes in Carasent AB (publ)

Carasent
Regulatory press release5/29/2026, 5:00 AM

Förändring av antalet aktier och röster i Carasent AB (publ)

Carasent
Regulatory press release5/20/2026, 1:08 PM

Finansinspektionen: Flaggningsmeddelande i Carasent AB (publ)

Carasent

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release4/27/2026, 4:23 PM

Redeye: Carasent: Broadening with lab solution in Sweden

Carasent
Press release4/27/2026, 8:17 AM

DNB Carnegie Access: Carasent: Announces acquisition of Infosolutions

Carasent
Regulatory press release4/27/2026, 6:00 AM

Carasent acquires Infosolutions and strengthens its position in Swedish private healthcare

Carasent
Regulatory press release4/27/2026, 6:00 AM

Carasent förvärvar Infosolutions och stärker sin position inom svensk privat vård

Carasent
Regulatory press release4/20/2026, 9:08 AM

Annual General Meeting in Carasent AB (publ)

Carasent
Regulatory press release4/20/2026, 9:08 AM

Årsstämma i Carasent AB (publ)

Carasent
Press release4/15/2026, 9:09 AM

Redeye: Carasent (Q1 review): Medsum momentum and German milestone

Carasent
Press release4/15/2026, 4:51 AM

DNB Carnegie Access: Carasent: Focus on recurring revenue – Q1 review

Carasent
Press release4/14/2026, 11:26 AM

Redeye: Carasent (Q1 initial take): Strong ARR, but profitability below expectations on higher costs and softer consulting

Carasent
Press release4/14/2026, 6:46 AM

DNB Carnegie Access: Carasent: Miss on headline but recurring revenue strong – Q1 initial

Carasent
Carasent, Audiocast, Q1'26
Webcast4/14/2026, 6:00 AM

Carasent, Audiocast, Q1'26

Carasent
Regulatory press release4/14/2026, 5:00 AM

Carasent AB (publ) – interim report Q1 2026

Carasent
Regulatory press release4/14/2026, 5:00 AM

Carasent AB (publ) – delårsrapport januari – mars 2026

Carasent
Regulatory press release4/8/2026, 7:15 AM

Carasent AB (publ) – Invitation to presentation of Q1 2026 results

Carasent
Regulatory press release4/8/2026, 7:15 AM

Carasent AB (publ) – Inbjudan till presentation av det första kvartalet 2026

Carasent
Press release3/31/2026, 5:27 PM

DNB Carnegie Access: Carasent: Ticks a lot of boxes in an uncertain environment – Q1 preview

Carasent
Regulatory press release3/19/2026, 5:00 PM

Notice of Annual General Meeting in Carasent AB (publ)

Carasent